老视治疗的临床进展  

Clinical progress of the treatment of presbyopia

作　　者：李璟 王晶[2] Li Jing;Wang Jing(Department of Ophthalmology,Eye Hospital,Wenzhou Medical University,Zhejiang Eye Hospital,Wenzhou 325027,China;Department of Ophthalmology,Jinan Second People′s Hospital,Jinan 250000,China)

机构地区：[1]温州医科大学附属眼视光医院眼科浙江省眼科医院,温州325027 [2]济南市第二人民医院眼科,济南250000

出　　处：《中华眼外伤职业眼病杂志》2023年第1期63-68,共6页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：老视是一种与年龄相关的生理现象,是身体开始衰老的信号之一。随着年龄的增长,晶状体逐渐硬化,调节的能力减弱,出现视近困难,即老视,也就是俗称的"老花眼"。目前角膜和晶状体手术是临床老视矫正的主要热门方法,药物及动态调节眼镜、电子人工晶状体等新技术也在不断开发研究中。本文就老视的发生机制、治疗方法及其进展等相关文献作一综述。Presbyopia is an age-related physiological phenomenon and one of the signs that the body is beginning to age.With the growth of age,the lens gradually hardens,and the ability to regulate light is weakened.When vision decreases and near-sight difficulties occur,it is commonly called presbyopia.At present,cornea and lens surgeries are the main methods for the correction of presbyopia,and new technologies such as drug,dynamic adjustment glasses,and electronic intraocular lens are also under continuous development and research.This article reviews the related research on the occurrence mechanism,treatment methods and progress of presbyopia.

关 键 词：老视 机制 发生 方法 治疗 前景 发展 

分 类 号：R778.14[医药卫生—眼科]